Almotriptan Sandoz 12,5 mg film-coat. tabl. Belgia - angielski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

almotriptan sandoz 12,5 mg film-coat. tabl.

sandoz sa-nv - almotriptan d,l-hydrogen malate 17,5 mg - eq. almotriptan 12,5 mg - film-coated tablet - 12,5 mg - almotriptan-d,l-hydrogen malate - almotriptan

ISOPTIN 80 Milligram Film Coated Tablet Irlandia - angielski - HPRA (Health Products Regulatory Authority)

isoptin 80 milligram film coated tablet

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 80 milligram

ISOPTIN 40 Milligram Film Coated Tablet Irlandia - angielski - HPRA (Health Products Regulatory Authority)

isoptin 40 milligram film coated tablet

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 40 milligram

ISOPTIN 120 Milligram Film Coated Tablet Irlandia - angielski - HPRA (Health Products Regulatory Authority)

isoptin 120 milligram film coated tablet

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 120 milligram

ALMOTRIPTAN MALATE- almotriptan tablet, film coated Stany Zjednoczone - angielski - NLM (National Library of Medicine)

almotriptan malate- almotriptan tablet, film coated

mylan pharmaceuticals inc. - almotriptan malate (unii: pjp312605e) (almotriptan - unii:1o4xl5sn61) - almotriptan 6.25 mg - almotriptan tablets (almotriptan malate) are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura. almotriptan tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated). almotriptan tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with almotriptan tablets, the diagnosis of migraine should be reconsidered before almotriptan tablets are administered to treat any subsequent attacks. in adolescents age 12 to 17 years, efficacy of almotriptan tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. almotriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine [see contraindications (4.7)] . safety and ef

APO-MOCLOBEMIDE moclobemide 300mg tablet blister pack Australia - angielski - Department of Health (Therapeutic Goods Administration)

apo-moclobemide moclobemide 300mg tablet blister pack

arrotex pharmaceuticals pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: methylcellulose; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; hypromellose; hyprolose; macrogol 8000; titanium dioxide - treatment of major depression.

ALMOTRIPTAN TABLET Kanada - angielski - Health Canada

almotriptan tablet

pro doc limitee - almotriptan (almotriptan malate) - tablet - 12.5mg - almotriptan (almotriptan malate) 12.5mg - selective serotonin agonists

Akilen 40mg Tablet Malta - angielski - Medicines Authority

akilen 40mg tablet

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - verapamil hydrochloride - film-coated tablet - verapamil hydrochloride 40 mg - calcium channel blockers

APO-MOCLOBEMIDE moclobemide 150mg tablet blister pack Australia - angielski - Department of Health (Therapeutic Goods Administration)

apo-moclobemide moclobemide 150mg tablet blister pack

arrotex pharmaceuticals pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: dextrates; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; hypromellose; polydextrose; macrogol 3350; titanium dioxide; iron oxide yellow; carnauba wax - treatment of major depression.